Eve Tomlinson

TL;DR: This is a protocol for a Cochrane Review to assess whether SARS-CoV-2-neutralising mAbs are effective and safe for treating patients with COVID-19 in comparison to an active comparator, placebo or no intervention.

TL;DR: This protocol is a protocol for a Cochrane Review (intervention) to assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, and to maintain the currency of the evidence using a living systematic review approach.

TL;DR: There is no evidence from good quality studies on the best strategies to reduce the time to diagnosis of brain tumours, despite the prioritisation of research on early diagnosis by the James Lind Alliance in 2015.

TL;DR: In this article , the authors present seven highly desirable factors for research teams to consider during identification and invitation of individual representatives in a multi-stakeholder research partnership, including expertise or experience, ability and willingness to represent the stakeholder group, inclusivity (equity, diversity and intersectionality), communication skills, commitment and time capacity, financial and non-financial relationships and activities, and conflict of interest.

TL;DR: The new equity group as mentioned in this paper aims to promote equity in the evidence base, ensure equitable processes for stakeholder engagement, produce high-priority, equity-focused evidence syntheses, and build capacity for equity design, analysis, and reporting.